LU85696A1 - 5-pyrimidine-carboxamides et thiocarboxamides,ainsi que le traitement de la leucemie et des tumeurs avec ces substances - Google Patents

5-pyrimidine-carboxamides et thiocarboxamides,ainsi que le traitement de la leucemie et des tumeurs avec ces substances Download PDF

Info

Publication number
LU85696A1
LU85696A1 LU85696A LU85696A LU85696A1 LU 85696 A1 LU85696 A1 LU 85696A1 LU 85696 A LU85696 A LU 85696A LU 85696 A LU85696 A LU 85696A LU 85696 A1 LU85696 A1 LU 85696A1
Authority
LU
Luxembourg
Prior art keywords
group
carboxamide
pyrimidine
hydroxy
oxo
Prior art date
Application number
LU85696A
Other languages
English (en)
French (fr)
Inventor
Arthur D Brewer
John A Minatelli
Original Assignee
Uniroyal Inc
Uniroyal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniroyal Inc, Uniroyal Ltd filed Critical Uniroyal Inc
Publication of LU85696A1 publication Critical patent/LU85696A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/66—Thiobarbituric acids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU85696A 1983-12-19 1984-12-19 5-pyrimidine-carboxamides et thiocarboxamides,ainsi que le traitement de la leucemie et des tumeurs avec ces substances LU85696A1 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US56269383A 1983-12-19 1983-12-19
US56269383 1983-12-19
US66520184A 1984-10-26 1984-10-26
US66526784A 1984-10-26 1984-10-26
US66526784 1984-10-26
US66520184 1984-10-26

Publications (1)

Publication Number Publication Date
LU85696A1 true LU85696A1 (fr) 1985-09-12

Family

ID=27415896

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85696A LU85696A1 (fr) 1983-12-19 1984-12-19 5-pyrimidine-carboxamides et thiocarboxamides,ainsi que le traitement de la leucemie et des tumeurs avec ces substances

Country Status (19)

Country Link
US (1) US4634707A (da)
JP (1) JPH0660164B2 (da)
AT (1) AT394194B (da)
AU (1) AU580746B2 (da)
BE (1) BE901301A (da)
CH (1) CH671225A5 (da)
DE (1) DE3446371A1 (da)
DK (1) DK164055C (da)
ES (1) ES8606296A1 (da)
FR (1) FR2557108B1 (da)
GB (1) GB2152047B (da)
GR (1) GR82494B (da)
IE (1) IE57675B1 (da)
IL (1) IL73840A (da)
IT (1) IT1213257B (da)
LU (1) LU85696A1 (da)
NL (1) NL8403856A (da)
NZ (2) NZ210599A (da)
SE (1) SE469171B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145087B (en) * 1983-08-19 1987-02-04 Ciba Geigy Ag Barbituric acid derivatives
EP0167491A3 (de) * 1984-07-06 1986-12-30 Ciba-Geigy Ag Thiobarbitursäurederivate
PH24423A (en) * 1985-02-15 1990-06-25 Ciba Geigy Ag 5-(azolyloxyphenylcarbamoyl)barbituric acid derivatives as anthelmintics
US4636508A (en) * 1985-04-22 1987-01-13 Uniroyal Chemical Company, Inc. 5-pyrimidinecarboxyamides and treatment of leukemia therewith
US4845217A (en) * 1985-05-17 1989-07-04 Uniroyal Chemical Ltd./Ltee Purification of 5-pyrimidinecarboxamides
EP0202823A3 (en) * 1985-05-17 1987-11-19 Uniroyal Limited Purification of 5-pyrimidinecarboxamides
US4880811A (en) * 1987-06-24 1989-11-14 Memorial Hospital For Cancer And Allied Diseases Use of C-5 mono-substituted barbiturates to treat disorders of uric acid metabolism
US4920126A (en) * 1988-05-10 1990-04-24 Uniroyal Chemical Ltd/Uniroyal Chemical Ltee Barbituric acid derivative and treatment of leukemia and tumors therewith
WO1991013623A1 (en) * 1990-03-09 1991-09-19 Memorial Hospital For Cancer And Allied Diseases C-5 mono-substituted barbiturates in combination with therapeutic agents and uses thereof
AU2001257230B2 (en) 2000-04-24 2006-09-14 Aryx Therapeutics Ultrashort acting hypnotic barbiturates
US10093631B2 (en) * 2014-02-14 2018-10-09 Acquist Llc Bifunctional compounds and use for reducing uric acid levels
EP3247704A4 (en) * 2015-01-22 2018-10-03 Acquist LLC Bifunctional compounds and use for reducing uric acid levels
TWI772309B (zh) * 2016-06-30 2022-08-01 美商艾克奎斯特有限責任公司 化合物及其於降低尿酸位準之用途(二)
WO2018009615A1 (en) 2016-07-06 2018-01-11 Acquist Llc Compounds and their use for reducing uric acid levels
IT201700028709A1 (it) * 2017-03-15 2018-09-15 Fondazione St Italiano Tecnologia Acidi-5-carbossamide-2-tiobarbiturici e loro uso come medicamenti

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH602664A5 (en) * 1973-06-14 1978-07-31 Sandoz Ag 2-Tert. amino-alkylamino-pyrimidine derivs.
DE2405733C2 (de) * 1974-02-07 1984-12-13 Bayer Ag, 5090 Leverkusen Amidocarbonylthiobarbitursäurederivate und deren Salze, Verfahren zu ihrer Herstellung sowie ihre Verwendung zur Bekämpfung von Insekten, Milben und Pilzen
DE2405732A1 (de) * 1974-02-07 1975-08-21 Bayer Ag Ekto- und endoparasitenmittel
CH614944A5 (en) * 1974-04-16 1979-12-28 Sandoz Ag Process for the preparation of novel pyrimidine derivatives
CH616563A5 (en) * 1976-05-06 1980-04-15 Ciba Geigy Ag Pesticide containing a 5-phenylcarbamoylbarbituric acid as active ingredient
PL103086B1 (pl) * 1976-05-06 1979-05-31 Ciba Geigy Ag Srodek owadobojczy
DE2624856A1 (de) * 1976-06-03 1977-12-22 Hoechst Ag 2-thiohexahydropyrimidin-4,6-dion-derivate und verfahren zu ihrer herstellung
US4283444A (en) * 1978-09-12 1981-08-11 Ciba-Geigy Corporation Method of protecting keratinous material from attack by insects that feed on keratin by treatment with 5-phenylcarbamoylbarbituric acid compounds
DE2962834D1 (en) * 1978-10-30 1982-07-01 Fujisawa Pharmaceutical Co 5-fluorouracil derivatives, preparation thereof and their pharmaceutical compositions
US4349552A (en) * 1978-10-30 1982-09-14 Fujisawa Pharmaceutical Company, Ltd. 5-Fluorouracil derivatives, and their pharmaceutical compositions
CH654720A5 (de) * 1981-09-03 1986-03-14 Ciba Geigy Ag Lagerstabile mottenschutzformulierungen.
US4410524A (en) * 1982-06-01 1983-10-18 American Cyanamid Company Novel 1,4-bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
GB2126582B (en) * 1982-08-26 1986-03-05 Ciba Geigy Ag Phenyl carbamoyl barbituric acid anthelmintics
CH658770A5 (de) * 1982-08-26 1986-12-15 Ciba Geigy Ag Motten- und kaeferschutzmittel.
ZA849819B (en) * 1983-12-19 1985-07-31 Uniroyal Inc 5-pyrimidinecarboxamides and thiocarboxamides and treatment of leukemia and tumors therewith
EP0167491A3 (de) * 1984-07-06 1986-12-30 Ciba-Geigy Ag Thiobarbitursäurederivate
JPS641445A (en) 1987-06-22 1989-01-05 Toshiba Corp Manufacture of stator coil

Also Published As

Publication number Publication date
IL73840A0 (en) 1985-03-31
BE901301A (fr) 1985-06-18
IE843237L (en) 1985-06-19
DK609184A (da) 1985-06-20
GB2152047B (en) 1988-04-27
JPS62174058A (ja) 1987-07-30
DK609184D0 (da) 1984-12-18
SE8406450L (sv) 1985-06-20
GB2152047A (en) 1985-07-31
IT8424104A0 (it) 1984-12-18
DK164055B (da) 1992-05-04
GB8432112D0 (en) 1985-01-30
ATA402684A (de) 1991-08-15
FR2557108A1 (fr) 1985-06-28
DE3446371A1 (de) 1985-06-27
IT1213257B (it) 1989-12-14
JPH0660164B2 (ja) 1994-08-10
CH671225A5 (da) 1989-08-15
AU3690884A (en) 1985-07-04
NL8403856A (nl) 1985-07-16
US4634707A (en) 1987-01-06
IE57675B1 (en) 1993-02-24
SE469171B (sv) 1993-05-24
DE3446371C2 (da) 1990-08-16
GR82494B (en) 1985-04-19
IL73840A (en) 1988-11-15
AT394194B (de) 1992-02-10
ES8606296A1 (es) 1986-04-16
ES538829A0 (es) 1986-04-16
FR2557108B1 (fr) 1988-11-18
AU580746B2 (en) 1989-02-02
NZ220399A (en) 1987-09-30
DK164055C (da) 1992-09-28
SE8406450D0 (sv) 1984-12-18
NZ210599A (en) 1987-09-30

Similar Documents

Publication Publication Date Title
LU85696A1 (fr) 5-pyrimidine-carboxamides et thiocarboxamides,ainsi que le traitement de la leucemie et des tumeurs avec ces substances
EP0042593A1 (de) Aryloxypropanolamine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH620925A5 (da)
CA1197247A (fr) Procede pour la preparation de nouveaux derives d'imidazotetrazinones et les derives ainsi obtenus
FR2580642A1 (fr) 5-pyrimidinecarboxamides et traitement de la leucemie et des tumeurs en les utilisant
CA1213892A (fr) Procede de preparation de nouveaux derives de la sulfonyluree
FR2464259A1 (fr) Nouvelles 5-(2-chlorophenyl)-6h-1,3,4-thiadiazine-2-amines, utiles notamment comme anticonvulsivants, et leur procede de preparation
EP0772630B1 (fr) Derives de streptogramine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2499991A1 (fr) Nouveaux 2,1,3-benzothiadiazoles et 2,1,3-benzoxadiazoles, leur preparation et leur application comme medicaments
FR2609033A1 (fr) Derives de la pyrimidine, leur preparation et compositions les contenant
KR850000210B1 (ko) 옥사졸린의 제조방법
JPH0441145B2 (da)
FR2477151A1 (fr) Derives de la piperazine, leur preparation et leurs utilisations en medecine
DE2038922A1 (de) Organische Thiazolopyrimidine
BE1001262A4 (fr) Procede en vue de provoquer la regression de la leucemie et l'inhibition de la croissance des tumeurs chez les mammiferes.
DE2325036A1 (de) Arylenverbindungen
DE2416608A1 (de) Neue 5-aryl-pyrido-(b-6,7)-1,4-diazepine mit einem weiteren annellierten heterocyklus
LU87274A1 (fr) Procede en vue de provoquer la regression de la leucemie et l'inhibition de la croissance des tumeurs chez les mammiferes
HU196784B (en) Process for production of substituated-1h-indasoles and medical compositions containing theam as active substance
FR2628869A1 (da)
JPS59106485A (ja) アクリダノン誘導体
WO1995004034A1 (de) (thio)carbamidinsäure-derivate und diese enthaltende arzneimittel
EP0028455A1 (en) 5-Phenylselenobenzimidazole derivatives, their preparation and anthelmintic or fasciolicidal compositions containing them
JPH03501730A (ja) １‐アラルキル‐１，２‐ジヒドロピリミジン‐２‐チオン類
LU87275A1 (fr) Procede en vue de provoquer la regression de la leucemie et l'inhibition de la croissance des tumeurs chez les mammiferes